Literature DB >> 23738829

Co-occurrence of ACSSuT and cephalosporin resistance phenotypes is mediated by int1-associated elements in nontyphoidal Salmonella enterica from human infections in Spain.

Maria Jorge Campos1, Gonzalo Palomo, Lorena Hormeño, María Ugarte, María Concepción Porrero, Silvia Herrera-León, Santiago Vadillo, Segundo Píriz, Alberto Quesada.   

Abstract

A screening of antimicrobial resistance and its genetic determinants has been performed on 300 Salmonella enterica isolates collected during 2004-2008 from human infections in Spain. Salmonella Typhimurium and Salmonella Enteritidis were the major serotypes, which were found with similar frequencies covering 80% of the bacterial collection. Salmonella Typhimurium isolates frequently shared low susceptibility to antimicrobials of the penta-resistance phenotype (ACSSuT) and/or cephalosporin resistance. The ACSSuT profile was found closely linked to int1-associated gene cassettes, with major elements carrying DNA fragments of 1.0 Kb (aadA2 gene) plus 1.2 Kb (blaPSE-1 gene) or 2.0 Kb (aadA1 and blaOXA-1 genes). Among these, ACSSuT and cephalosporin resistances were associated in Salmonella Typhimurium isolates expressing the blaOXA gene. β-lactamase activities were also detected from isolates carrying blaTEM, blaCMY, or blaSHV, although only the two last genes expressed extended-spectrum β-lactamases. The clonal analysis of S. enterica strains suggests that both horizontal and vertical transfer mechanisms are involved in the wide dissemination of their antimicrobial resistance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23738829     DOI: 10.1089/mdr.2012.0261

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  1 in total

1.  Comparative characterization of nontyphoidal Salmonella isolated from humans and food animals in China, 2003-2011.

Authors:  Congming Wu; Meiyin Yan; Lizhang Liu; Jing Lai; Edward Wai-Chi Chan; Sheng Chen
Journal:  Heliyon       Date:  2018-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.